Allena Pharmaceuticals, Inc.
ALNAQ · OTC
12/31/2021 | 12/31/2020 | 12/31/2019 | 12/31/2018 | |
|---|---|---|---|---|
| Market Cap | $19,260 | $41,609 | $60,554 | $113,040 |
| - Cash | $29,988 | $35,042 | $30,007 | $61,643 |
| + Debt | $527 | $10,144 | $10,478 | $9,980 |
| Enterprise Value | -$10,201 | $16,711 | $41,025 | $61,377 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | – | – | – | – |
| EBITDA | -$31,972 | -$33,189 | -$47,176 | -$35,570 |
| % Margin | – | – | – | – |
| Net Income | -$33,355 | -$32,845 | -$47,339 | -$35,648 |
| % Margin | – | – | – | – |
| EPS Diluted | -1.03 | -1.01 | -2.13 | -1.72 |
| % Growth | -2% | 52.6% | -23.8% | – |
| Operating Cash Flow | -$45,678 | -$28,159 | -$43,632 | -$31,839 |
| Capital Expenditures | -$667 | -$650 | -$122 | -$318 |
| Free Cash Flow | -$46,345 | -$28,809 | -$43,754 | -$32,157 |